Endogenous Scedosporium apiospermum endophthalmitis.
Jain
Atul
A
Egbert
Peter
P
McCulley
Timothy J
TJ
Blumenkranz
Mark S
MS
Moshfeghi
Darius M
DM
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D001082:Aqueous Humor / Q000378:metabolism / Q000382:microbiology; D001682:Biological Availability; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015821:Eye Infections, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D017809:Fatal Outcome; D005260:Female; D016469:Fungemia / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008875:Middle Aged; D008271:Mycetoma / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D011743:Pyrimidines / Q000493:pharmacokinetics / Q000627:therapeutic use; D021681:Scedosporium / Q000302:isolation & purification*; D014230:Triazoles / Q000493:pharmacokinetics / Q000627:therapeutic use; D014822:Vitreous Body / Q000378:metabolism / Q000382:microbiology; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole